title: Prosthetic heart valves.
abstract: The first prosthetic valve was implanted by Hufnagel in 1952 in a patient with aortic insufficiency. Since then, prosthetic valves have evolved into various mechanical and bioprosthetic shapes and sizes. Despite the excitement surrounding the current development of prosthetic heart valves, surgically implanted valves remain the mainstay of current practice, and this article discusses the hemodynamic issues associated with the more commonly placed valves.
authors: Division of Cardiology, Department of Internal Medicine, Saint Louis University School of Medicine, 3635 Vista Avenue, 13th Floor, Desloge Towers, St Louis, MO 63110-0250, USA.
authors: C Ryan
authors: CR
authors: Longnecker
authors: Michael J
authors: MJ
authors: Lim
mesh_terms: D001021:Aortic Valve / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D001705:Bioprosthesis; D006328:Cardiac Catheterization; D002933:Cineradiography; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D017548:Echocardiography, Transesophageal; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006349:Heart Valve Diseases / Q000150:complications / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D006350:Heart Valve Prosthesis / Q000592:standards*; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006439:Hemodynamics; D006801:Humans; D008943:Mitral Valve / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D008991:Monitoring, Physiologic; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents